Several major US-listed global hotel chains reported strong performance in China in the first quarter, driven by robust business and leisure demand, with momentum expected to continue through the year. As US President Donald Trump makes a state visit to Beijing this week, international arrivals to China also jumped in the first quarter, fuelled by the country’s expanded visa-free entry policies fo...
Several major US-listed global hotel chains reported strong performance in China in the first quarter, driven by robust business and leisure demand, with momentum expected to continue through the year. As US President Donald Trump makes a state visit to Beijing this week, international arrivals to China also jumped in the first quarter, fuelled by the country’s expanded visa-free entry policies for more countries. Four international hotel groups – Hilton Worldwide Holdings, InterContinental...
Major Bank Faces Legal Heat Over Allegations Of Debanking Conservatives Capital One is under fire once again over allegations that it has denied banking services to gun retailers and other customers viewed as politically conservative, even as President Donald Trump’s executive actions seek to curb such practices. A Maryland gun store, United Gun Shop of Rockville, recently filed a lawsuit alleging...
Major Bank Faces Legal Heat Over Allegations Of Debanking Conservatives Capital One is under fire once again over allegations that it has denied banking services to gun retailers and other customers viewed as politically conservative, even as President Donald Trump’s executive actions seek to curb such practices. A Maryland gun store, United Gun Shop of Rockville, recently filed a lawsuit alleging that Capital One, working through payment processor Melio Payments, blocked it from using the bank’s platform for business transactions after flagging its operations in the firearms industry. The store received notices in 2025 and 2026 stating that Capital One and Melio could not serve businesses in that sector, according to the legal complaint. The case has drawn attention from Consumers’ Research, a conservative watchdog group, which on Thursday issued a “ woke alert ” highlighting the allegations against the bank. “ Capital One has been caught debanking law-abiding citizens again . It apparently isn’t enough for Capital One to fund and promote racist DEI, climate activism, and extreme transgender policies; the company is also debanking its own customers simply for holding views outside leftist ideology,” Consumers’ Research Executive Director Will Hild said in a statement to The Daily Wire . 🚨 Despite President Trump’s executive order banning debanking, @CapitalOne is already facing new allegations in a lawsuit from a Maryland gun shop. United Gun Shop claims the bank effectively debanked them — not for fraud, not for any illegal activity, but seemingly because… pic.twitter.com/q6sIIMDBXA — Will Hild (@WillHild) May 8, 2026 Capital One is among nine large banks under review by the Office of the Comptroller of the Currency as part of that broader inquiry, the outlet pointed out. Capital One is also facing ongoing litigation in Florida after a federal judge in Miami dismissed a lawsuit brought by the Trump Organization accusing Capital One of politically motivated "debank...
According to a Securities and Exchange Commission (SEC) filing dated May 14, 2026, Owls Nest Partners IA, LLC sold its entire stake in nCino (NASDAQ:NCNO) , amounting to a change of 1,585,623 shares. The estimated transaction value was $29.79 million, calculated using average unadjusted closing prices from January through March 2026. The quarter-end value of the position declined by $40.66 million...
According to a Securities and Exchange Commission (SEC) filing dated May 14, 2026, Owls Nest Partners IA, LLC sold its entire stake in nCino (NASDAQ:NCNO) , amounting to a change of 1,585,623 shares. The estimated transaction value was $29.79 million, calculated using average unadjusted closing prices from January through March 2026. The quarter-end value of the position declined by $40.66 million, a figure that includes stock price movements during the period. nCino, Inc. operates at scale as a leading provider of cloud-based banking software, with a focus on process automation and regulatory compliance for financial institutions. The company's SaaS platform enables banks and credit unions to streamline operations, manage risk, and improve customer onboarding and loan origination. nCino's competitive advantage lies in its deep integration of data analytics and AI/ML capabilities, supporting digital transformation across the banking sector. Continue reading
The Trade Desk (NASDAQ: TTD) is competing against giants in the advertising industry. *Stock prices used were the afternoon prices of May 12, 2026. The video was published on May 14, 2026. Continue reading
The Trade Desk (NASDAQ: TTD) is competing against giants in the advertising industry. *Stock prices used were the afternoon prices of May 12, 2026. The video was published on May 14, 2026. Continue reading
BigBear.ai (NYSE: BBAI) is one of the most popular AI stocks on the market. *Stock prices used were the afternoon prices of May 12, 2026. The video was published on May 14, 2026. Continue reading
BigBear.ai (NYSE: BBAI) is one of the most popular AI stocks on the market. *Stock prices used were the afternoon prices of May 12, 2026. The video was published on May 14, 2026. Continue reading
AMD (NASDAQ: AMD) stock is soaring, and investors are curious if it is too late to buy. *Stock prices used were the afternoon prices of May 12, 2026. The video was published on May 14, 2026. Continue reading
AMD (NASDAQ: AMD) stock is soaring, and investors are curious if it is too late to buy. *Stock prices used were the afternoon prices of May 12, 2026. The video was published on May 14, 2026. Continue reading
Applovin (NASDAQ: APP) is the most profitable company I follow. *Stock prices used were the afternoon prices of May 12, 2026. The video was published on May 14, 2026. Continue reading
Applovin (NASDAQ: APP) is the most profitable company I follow. *Stock prices used were the afternoon prices of May 12, 2026. The video was published on May 14, 2026. Continue reading
The smartphone industry faces headwinds due to higher component prices. *Stock prices used were the afternoon prices of May 12, 2026. The video was published on May 14, 2026. Continue reading
The smartphone industry faces headwinds due to higher component prices. *Stock prices used were the afternoon prices of May 12, 2026. The video was published on May 14, 2026. Continue reading
On May 14, 2026, S Squared Technology disclosed a complete sale of its Ambarella (NASDAQ:AMBA) position, an estimated $8.02 million trade based on quarterly average pricing. According to a recent SEC filing dated May 14, 2026, S Squared Technology sold its entire holding of 128,551 Ambarella shares during the first quarter. The estimated transaction value is $8.02 million, based on the average clo...
On May 14, 2026, S Squared Technology disclosed a complete sale of its Ambarella (NASDAQ:AMBA) position, an estimated $8.02 million trade based on quarterly average pricing. According to a recent SEC filing dated May 14, 2026, S Squared Technology sold its entire holding of 128,551 Ambarella shares during the first quarter. The estimated transaction value is $8.02 million, based on the average closing price for the quarter ending March 31, 2026. The position’s quarter-end value declined by $9.11 million, a change that reflects both the sale and price movement during the period. Ambarella is a leading provider of semiconductor solutions specializing in video processing and artificial intelligence for a diverse range of applications, including automotive, security, and robotics. The company leverages proprietary system-on-a-chip technology to deliver high-quality video, advanced image processing, and efficient AI workloads at low power consumption. Ambarella's strategy centers on enabling next-generation intelligent cameras and autonomous systems, positioning it as a key technology partner for OEMs seeking innovation in video and vision-based products. Continue reading
The company announced a massive layoff, spooking investors. *Stock prices used were the afternoon prices of May 12, 2026. The video was published on May 14, 2026. Continue reading
The company announced a massive layoff, spooking investors. *Stock prices used were the afternoon prices of May 12, 2026. The video was published on May 14, 2026. Continue reading
Earnings Call Insights: Celcuity (CELC) Q1 2026 Management View CEO Brian Sullivan said, "We continue to make great progress as we prepare for the potential approval and commercial launch of gedatolisib in the third quarter," and added that, with positive VIKTORIA-1 readouts across cohorts, "we believe gedatolisib is well positioned to become the new standard of care second-line therapy for patien...
Earnings Call Insights: Celcuity (CELC) Q1 2026 Management View CEO Brian Sullivan said, "We continue to make great progress as we prepare for the potential approval and commercial launch of gedatolisib in the third quarter," and added that, with positive VIKTORIA-1 readouts across cohorts, "we believe gedatolisib is well positioned to become the new standard of care second-line therapy for patients with HR-positive/HER2-negative advanced breast cancer." Sullivan highlighted the near-term catalyst and disclosure timing, saying VIKTORIA-1 mutant cohort results will be presented "at a late-breaking abstract oral session at the 2026 ASCO meeting on June 2," and management reiterated, "we'll not be answering questions regarding these results during the Q&A portion of our call." Sullivan announced two development-plan updates, including "the expansion of our Phase III VIKTORIA-2 trial to include a second study" in first-line endocrine-sensitive disease and said the company is also "advancing the development of a gedatolisib formulation for subcutaneous injection" with "our first patent application" submitted. On regulatory sequencing, Sullivan said, "we remain optimistic about the outcome of the FDA's review of our NDA," and outlined that, "assuming our NDA is approved, we intend to submit the FDA a supplemental new drug application based on the results of the PIK3CA mutant cohort." CFO Vicky Hahne reported, "Our first quarter net loss was $52.8 million or $0.97 per share," and said, "Cash, cash equivalents and short-term investments were $387.1 million at the end of first quarter 2026" with funding expected "through 2027." Outlook Sullivan reiterated the company’s timing focus on the pending FDA action, saying there has been "nothing about the interactions to date that suggests that we will be off track for the PDUFA decision by July 17." On VIKTORIA-2 timelines after the design expansion, Sullivan said for Study 1 (endocrine-resistant) "We expect to have top line data ...